Respiratory disease burden associated with Human Metapneumovirus across all ages in Scotland and comparison with Respiratory Syncytial Virus burden

Project Details

StatusActive
Effective start/end date1/12/2431/03/26

Funding

  • Astra Zeneca: £128,813.86